Annual VANGUARD meeting held in Igls, Austria
Team members of the VANGUARD project travelled to Igls in Austria for the annual consortium meeting which was held on 22 January 2023. The full day meeting covered the research progress of all work packages in the first three years of the project, the next steps planned and enough time for lively discussions between representatives […]
VANGUARD publication on Advances and challenges of endocrine pancreas bioengineering available online
A new VANGUARD article has recently been published in Current Opinion in Endocrine and Metabolic Research. “Advances and challenges of endocrine pancreas bioengineering” – Islet transplantation is a valid treatment option for type 1 diabetes patients. Despite the advantages of this intervention, many obstacles limit its efficacy such as the loss of islets during the […]
VANGUARD Ethics Workshop
Bio-artificial organs and bio-engineered or bio-printed tissues for transplantation in humans are rapidly being developed. It is anticipated that some applications will be ready for clinical testing in the near future. How can first-in-human clinical trials be conducted in a safe and responsible manner? What are ethical points to consider for early clinical trials of […]
Research article: Efficient and safe correction of hemophilia A by lentiviral vector-transduced BOECs in an implantable device
A new VANGUARD research article on Efficient and safe correction of hemophilia A by lentiviral vector-transduced BOECs in an implantable device has been published in Molecular Therapy, Methods & Clinical Development. The full article can be read online: https://doi.org/10.1016/j.omtm.2021.10.015 Abstract: Hemophilia A (HA) is a rare bleeding disorder caused by deficiency/dysfunction of the FVIII protein. […]
